Literature DB >> 17110240

Cholesterol profile measurement by vertical auto profile method.

Krishnaji R Kulkarni1.   

Abstract

Vertical auto profile (VAP) method is a direct single test for measuring comprehensive lipoprotein cholesterol profile. It is based on a well-established method of ultracentrifugation that uses vertical rotor and single density gradient spin. VAP provides cholesterol concentrations of total lipoprotein, high-density lipoprotein (HDL), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), lipoprotein(a) (Lp(a)), intermediate-density lipoprotein (IDL), HDL subclasses (HDL2 and HDL3), LDL subclasses (LDL1, LDL2, LDL3, and LDL4), VLDL subclasses (VLDL1, VLDL2, and VLDL3), and LDL maximum time, which is directly proportional to LDL size. Because VAP measures additional lipoprotein classes, such as Lp(a), IDL, and subclasses of HDL, LDL, and VLDL, it can identify patients at high risk for coronary heart disease who cannot be identified using the standard lipid panel. In addition, the VAP method is compliant with the National Cholesterol Education Program's Adult Treatment Panel III guidelines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17110240     DOI: 10.1016/j.cll.2006.07.004

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  59 in total

1.  Early atherogenesis and visceral fat in obese adolescents.

Authors:  A H Slyper; H Rosenberg; A Kabra; M J Weiss; B Blech; S Gensler; M Matsumura
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

2.  HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

Authors:  Seth S Martin; Arif A Khokhar; Heidi T May; Krishnaji R Kulkarni; Michael J Blaha; Parag H Joshi; Peter P Toth; Joseph B Muhlestein; Jeffrey L Anderson; Stacey Knight; Yan Li; John A Spertus; Steven R Jones
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

3.  Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapy.

Authors:  James M Backes; Cheryl A Gibson; Janelle F Ruisinger; Patrick M Moriarty
Journal:  Lipids       Date:  2011-07-08       Impact factor: 1.880

4.  Abnormalities of lipoprotein concentrations in obstructive sleep apnea are related to insulin resistance.

Authors:  Alice Liu; James Cardell; Danit Ariel; Cindy Lamendola; Fahim Abbasi; Sun H Kim; Tyson H Holmes; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Clete A Kushida; Gerald M Reaven
Journal:  Sleep       Date:  2015-05-01       Impact factor: 5.849

5.  Effect of Pioglitazone on Cardiometabolic Risk in Patients With Obstructive Sleep Apnea.

Authors:  Alice Liu; Fahim Abbasi; Sun H Kim; Danit Ariel; Cindy Lamendola; James Cardell; Shiming Xu; Shailja Patel; Vanessa Tomasso; Hafasa Mojaddidi; Kaylene Grove; Philip S Tsao; Clete A Kushida; Gerald M Reaven
Journal:  Am J Cardiol       Date:  2017-01-25       Impact factor: 2.778

6.  High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.

Authors:  Yashashwi Pokharel; Puza P Sharma; Mohammed Qintar; Yuan Lu; Yuanyuan Tang; Philip Jones; Rachel P Dreyer; John A Spertus
Journal:  Atherosclerosis       Date:  2017-09-18       Impact factor: 5.162

Review 7.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

8.  Modifiable factors associated with failure to attain low-density lipoprotein cholesterol goal at 6 months after acute myocardial infarction.

Authors:  Seth S Martin; Kensey Gosch; Krishnaji R Kulkarni; John A Spertus; Robin Mathews; P Michael Ho; Thomas M Maddox; L Kristin Newby; Karen P Alexander; Tracy Y Wang
Journal:  Am Heart J       Date:  2012-11-17       Impact factor: 4.749

9.  Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

10.  Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses.

Authors:  Paola Toledo-Ibelles; Cynthia García-Sánchez; Nydia Avila-Vazzini; Elizabeth Carreón-Torres; Carlos Posadas-Romero; Gilberto Vargas-Alarcón; Oscar Pérez-Méndez
Journal:  J Lipid Res       Date:  2010-01-23       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.